All participants in the Phase 3 clinical trial of Taiwan-based Medigen Vaccine Biologics Corp.'s COVID-19 vaccine in Paraguay have now received two shots of either the Medigen or AstraZeneca vaccine, the company said Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Sports
CPBL MVP finalist Lin An-ko exercises overseas free agency option
11/04/2025 05:46 PM - Society
THSR ridership hits new record high in October thanks to 3 long weekends
11/04/2025 05:40 PM - Society
Chiayi man gets toys confiscated, sent for auction over unpaid fines
11/04/2025 05:19 PM - Business
Taiwan shares end down as AI-related stocks on profit-taking
11/04/2025 04:55 PM - Culture
Taiwan Creative Content Fest begins; NT$1.5 billion funds launched
11/04/2025 04:36 PM